The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser. (NCT01878838) | Clinical Trial Compass
CompletedNot Applicable
The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.
United States45 participantsStarted 2013-04
Plain-language summary
This study compares two FDA approved Cataract Lasers.
Who can participate
Age range22 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Have grade 2 to 4 nuclear sclerotic and or cortical or posterior subcapsular cataracts with visual impairment.
* Pupillary dilation of at least 6.0 mm
* Axial length between 21 mm to 26 mm
* Age ≥ 22 years of either gender
* Require laser assisted corneal incisions, capsulotomy and nucleus segmentation
* Understand and sign a written Informed Consent form
* Be able to comply with the treatment and follow-up schedule
Exclusion Criteria:
* Enrolment in another drug or device study within the prior 3 months
* History of ocular trauma
* Acute or chronic disease or illness that would increase risk or confound study results (e.g., uncontrolled diabetes mellitus, immunocompromised, etc.)
* Uncontrolled systemic or ocular disease
* Corneal abnormalities (e.g., stromal, epithelial or endothelial dystrophies, severe corneal opacities, significant corneal edema, etc)
* Diminished aqueous clarity that obscures OCT imaging of the anterior lens capsule
* Corneal ring and/or inlay implant(s)
* Pseudoexfoliation
* Known steroid IOP responder or ocular hypertension IOP \>25 mmHg by tonometry
* Retinal detachment within the last 6 months
* Anterior chamber depth less than 2.5 mm